{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:32:32Z","timestamp":1790760752462,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T00:00:00Z","timestamp":1527292800000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A-159454"],"award-info":[{"award-number":["31003A-159454"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novartis Research Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bmcl.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T13:32:39Z","timestamp":1493904759000},"page":"2982-2985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phenylbenzenesulfonates and -sulfonamides as 17\u03b2-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Anna","family":"Vuorinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger T.","family":"Engeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Leugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Matuszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.05.005_b0005","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1359\/jbmr.1998.13.10.1539","article-title":"17Beta-hydroxysteroid dehydrogenases in human bone cells","volume":"13","author":"Dong","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bmcl.2017.05.005_b0010","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1210\/endo.140.7.6861","article-title":"Characterization of molecular and catalytic properties of intact and truncated human 17beta-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the endoplasmic reticulum","volume":"140","author":"Puranen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bmcl.2017.05.005_b0015","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1016\/S0021-9258(18)31480-7","article-title":"Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity","volume":"268","author":"Wu","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0020","first-page":"3710","article-title":"17Beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta: an immunohistochemical study with correlation to placental development","volume":"83","author":"Takeyama","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bmcl.2017.05.005_b0025","first-page":"1319","article-title":"Human 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle","volume":"83","author":"Mustonen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bmcl.2017.05.005_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-0215(19960328)66:1<37::AID-IJC7>3.0.CO;2-#","article-title":"Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate","volume":"66","author":"Elo","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmcl.2017.05.005_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/jme.0.0200067","article-title":"Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts","volume":"20","author":"Mustonen","year":"1998","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.bmcl.2017.05.005_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.12.010","article-title":"Estrogen and bone health in men and women","volume":"99","author":"Cauley","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.bmcl.2017.05.005_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bmcl.2017.05.005_b0050","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/jwh.2008.1086","article-title":"Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis","volume":"18","author":"Lewiecki","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.bmcl.2017.05.005_b0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2017.05.005_b0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14740338.2015.1014799","article-title":"Selective estrogen receptor modulators in clinical practice: a safety overview","volume":"14","author":"Ellis","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bmcl.2017.05.005_b0065","first-page":"267","article-title":"Effect of 17beta-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys","volume":"8","author":"Bagi","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.bmcl.2017.05.005_b0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/jm3014053","article-title":"Structural optimization of 2,5-thiophene amides as highly potent and selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis","volume":"56","author":"Marchais-Oberwinkler","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2011.09.004","article-title":"Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17beta-hydroxysteroid dehydrogenase type 2 (17beta-HSD2) inhibitors for the treatment of osteoporosis","volume":"47","author":"Wetzel","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bmc.2010.12.013","article-title":"17beta-HSD2 inhibitors for the treatment of osteoporosis: Identification of a promising scaffold","volume":"19","author":"Wetzel","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0085","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1016\/j.ejmech.2011.10.010","article-title":"Triazole ring-opening leads to the discovery of potent nonsteroidal 17beta-hydroxysteroid dehydrogenase type 2 inhibitors","volume":"46","author":"Xu","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0090","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm5004914","article-title":"Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17beta-hydroxysteroid dehydrogenase 2 inhibitors","volume":"57","author":"Vuorinen","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-2797(00)00171-X","article-title":"Comparative QSAR evidence for a free-radical mechanism of phenol-induced toxicity","volume":"127","author":"Hansch","year":"2000","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2017.05.005_b0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0009-2797(02)00258-2","article-title":"Quantitative structure toxicity relationships for phenols in isolated rat hepatocytes","volume":"145","author":"Moridani","year":"2003","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2017.05.005_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2003.12.006","article-title":"The role of 17 beta-hydroxysteroid dehydrogenases","volume":"218","author":"Mindnich","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bmcl.2017.05.005_b0110","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","article-title":"The role of 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension","volume":"1802","author":"Ferrari","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmcl.2017.05.005_b0115","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1021\/jm800054h","article-title":"Discovery of nonsteroidal 17\u03b2-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries","volume":"51","author":"Schuster","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.005_b0120","first-page":"129","article-title":"Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11\u03b2-hydroxysteroid dehydrogenase type 2","volume":"125","author":"Kratschmar","year":"2011","journal-title":"J Biochem Mol Biol"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17304869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17304869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:18:35Z","timestamp":1760771915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17304869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":24,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0960894X17304869"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.005","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylbenzenesulfonates and -sulfonamides as 17\u03b2-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}